Abstract. Collagen IV is a major component of vertebrate basal laminae (BLs). Studies in humans have revealed a family of genes encoding or-or6 collagen IV chains and implicated ot3-ot6 in disease processes (Goodpasture and Alport syndromes and diffuse leiomyomatosis). To extend studies of these components to an experimentally accessible animal, we cloned cDNAs encoding partial collagen t~3, u4, and ot5(iv) chains from the mouse. Ribonuclease protection assays showed that all three genes were expressed at highest levels in kidney and lung; ot5(iv) was also expressed at high levels in heart. We then made antibodies specific for each collagen IV chain. Immunohistochemical studies of several tissues revealed many combinations of collagen IV chains; however, t~3 and a4 (IV) were always coexpressed, and only appeared in BLs that were ot5(iv) positive. The ot3-ol5(iv) chains were frequently but not exclusively associated with the S (/32) chain of laminin, as were the or, 2 (IV) collagen chains with laminin B1 (/~1). An analysis of developing rat kidney BLs showed that newly formed (S-shaped) nephrons harbored collagen od and t~2(iv) and laminin B1; maturing (capillary loop stage) BLs contained collagen cd-ot5(iv) and laminin B1 and S-laminin; and mature glomerular BLs contained mainly collagen ot3-ot5(iv) and S-laminin. Thus, collagen otl and ot2(IV) and laminin B1 appear to be fetal components of the glomerular BL, and there is a developmental switch to collagen ot3-ot5(iv) and S-laminin expression.
collagen IV and some laminin, but in different isoform combinations, suggesting that the functional diversity of BLs arises in part from the particular collagen IV and laminin isoforms they contain.
Laminin subunit diversity was first demonstrated by the discoveries of S-laminin, a homologue of the B1 subunit (Hunter et al., 1989b) , and merosin M, a homologue of the A subunit (Ehrig et al., 1990) . More recently, K-laminin/nicein/kalinin/epiligrin laminin variants have been identified in subsets of epithelial BLs (Marinkovich et al., 1992; Kallunki et al., 1992) . The availability of numerous immunological and nucleic acid reagents is rapidly leading to an understanding of how these individual laminin subunits can be assembled. In tissues and in vitro, the B2 subunit associates with either the A or M heavy subunit plus either the B1 or S subunit, producing a heterogeneous family of laminin trimers Green et al., 1992) . At the cellular level, immunohistochemical studies have shown that most BLs contain either A or M, either B1 or S, and B2. For example, renal glomerular basement membrane (GBM) contains A, S, and B2, whereas extrasynaptic muscle BL contains M, B1, and B2 .
For the collagens IV, in contrast, details of chain assembly have been difficult to determine because the ot3-a6(IV) chains have been studied primarily in the context of diseased human tissue. The u3(iv) collagen chain was discovered as the antigen in Goodpasture syndrome, an autoimmune nephritis which targets the GBM in kidney and the alveolar BL in lung (Butkowski et al., 1987; Sans et al., 1988) . Attempts to purify tx30V) resulted in the discovery of the collagen ~x4(IV) chain, which appears to be associated with it (Gunwar et al., 1990; Johansson et al., 1992) . This work led to the hypothesis that either the collagen ix3 or a4(IV) chain was mutated in X-linked Alport syndrome, a hereditary glomerulonephritis known to involve defects in glomerular collagens. In fact, analysis of the mutant allele revealed that it encoded yet another chain, ct5(IV) Barker et al., 1990; Tryggvason et al., 1993) . Most recently, an tx6(IV) gene was identified next to the tx5(IV) gene and shown to be mutated in several X-linked cases of Alport syndrome in which mutations in ct5(IV) could not be detected Oohashi et al., 1994) . In addition, deletions that removed parts of both a5 and tx6(IV) were found when Alport syndrome was accompanied by diffuse leiomyomatosis, a benign proliferation of smooth muscle. The juxtaposed or5 and ot60V) genes are arranged in a headto-head orientation on the X chromosome, as are the coregulated txl and Ot2(IV) genes on human chromosome 13 (Poschl et al., 1988) . The o13 and tx4(IV) genes both map to human chromosome 2q35-37 and may be similarly arranged (Morrison et al., 1991; Turner et al., 1992; Mariyama et al., 1992b; Kamagata et al., 1992) .
Immunohistochemical studies have shown that the ot3-ot5(IV) collagen chains have a restricted distribution in human tissues. For example, they are highly enriched in the GBM (consistent with the Goodpasture and Alport syndrome phenotypes) and are also found in a subset of tubular basement membranes (TBMs) (Kleppel et al., 1989; Hostikka et al., 1990; Sanes et al., 1990; Kleppel et al., 1992; Hudson et al., 1992) . (No studies on the distribution of ot6(IV) have yet been reported.) On the other hand, the cd and ix2 chains of collagen IV are abundant in all TBMs and in the glomerular mesangial matrix, but are scarce in GBM (Kleppel et al., 1989; Kashtan and Kim, 1992; Sanes et al., 1990; Kleppel et al., 1992) . In human muscle, the ot3 and ot4(IV) collagen chains are restricted to the synaptic basal lamina at the neuromuscular junction, while the txl and c~2(IV) chains are found extrasynaptically . Interestingly, in both renal glomerular and muscle synaptic BLs the substitution of collagen oe3-a5(IV) chains for od and tx20V) is accompanied by a substitution of the S subunit of laminin for the B1 subunit.
Taken together, these results raise several questions concerning BL structure and function: Are there any general rules governing the patterns of collagen IV subunit expression in BLs? Is there a special association between collagen od-o~2(iv) and laminin B1, or between collagen o~3-o~5(IV) and S-laminin? Do collagens tx3-cz5(IV) have special roles in the GBM or in synaptic BL? Are particular BL isoforms (such as the linked pairs of collagen genes) coregulated during development? Here, to begin to address these questions, we have cloned cDNAs encoding partial collagen ot3-ot5(IV) chains from the mouse, prepared recombinant proteins from the cDNAs, and generated antibodies to the proteins. With these reagents, we performed RNase protection and immunohistochemical studies to analyze the expression patterns of the collagen IV chains in rodents. Of particular interest is the finding that the complement of collagen IV and laminin chains in the GBM changes systematically as development proceeds.
Materials and Methods

Polymerase Chain Reaction
The PCR was used to synthesize chain-specific collagen IV probes for screening mouse eDNA libraries. For ct3 and c~4(IV) collagen, bovine kidney poly A + RNA (Clontech, Palo Alto, CA) was reverse transcribed and amplified using the GeneAmp RNA PCR Kit (Perkin-Elmer Cetus, Norwalk, CT) with primers based on the published bovine sequences (Morrison et ai., 1991; Mariyama et al., 1992a) . Primers were: c~3(IV) sense, 5AA CCI"GGAGACACTGGACCACCTGC 3'; ct3(IV) antisense, 5'GTGCTT-GCCCAGCACCCTCCGAAC 3'; ot4(IV) sense, 5'CCTGGATACCTCA-GTGGCTTCCTCC 3'; and t~4(IV) antisense, 5'CAGGAACGGTGCGGC-TCTGAAATCC 3'. Thermal cycler conditions were: 95°C, I rain; 62°C, 1.5 rain; 72°C, 2 rain (+ 2 s/cycle), 33 cycles. PCR products were not visible by agarose gel electrophoresis after 33 cycles, so 5% of the sample was reamplified for 17 cycles, after which products of the expected length were detected. For collagen tx5(IV), we used adult mouse lung total RNA for reverse transcript (RT)-PCR with degenerate primers based on the published human sequence . The primers were: sense, 5AA(AG)GGNCA(AG)AG(CT)AT(ACT)CA(AG)CC 3'; antisense, 5'CTA-TC(GT)(CT)TTCAT(AG)CANAC(CT)TG(AG)CA 3'. Thermal cycler conditions were three cycles of 95°C, 1 rain; 51°C, 2.5 rain; 72°C, 2.5 rain, followed by 31 cycles of 950C, 1 rain; 55°C, 2.25 rain; 720C, 2.5 rain (+1 s/cycle). PCR products were ligated into the pCR II vector using a TA Cloning Kit (Invitrogen Corp., San Diego, CA) and analyzed by restriction enzyme digestion or sequencing.
cDNA Library Screening
The collagen IV fragments were liberated from the pCR II vector by digestion with EcoRI and isolated by agarose gel electrophoresis. The fragments were 32p-dCTP labeled with a Random Primed DNA Labeling Kit (Boehringer Mannheim Bit)chemicals, Indianapolis, IN). The bovine t~3 and ¢x4(IV) collagen fragments were used to screen a hgtll mouse kidney eDNA library (Clontech) at low stringency. Hybridization conditions were: 30% formamide, 900 mM NaCl, 90 mM sodium citrate, 50 mM NaPO, (pH = 6.5), 0.25 % nonfat dry milk, at 42°C overnight. The mouse collagen ct5(IV) fragment was used to screen a hgtll mouse muscle eDNA library (prepared and provided by Mafia J. Donoghue in our laboratory) as above, except in 50 % formamide. The inserts of hybridizing phage were subcloned into Blue, script (BS) II SK+ (Stratagene Cloning Systems, La Jolla, CA) and sequenced with a Sequenase 2.0 Sequencing Kit (United States Biochemical Corp., Cleveland, OH).
Probes for RNase Protections
The collagen cd(IV) riboprobe was derived from the plasmid pCIV-l-C87, a eDNA clone from an Engelbreth-Holm-Swarm library (Wood et al., 1988 ; obtained from the American Type Culture Collection, Rockville, MD). Its 676-bp StyI fragment was blunted, subcloned into the EcoRV site of BS II SK+, cut with BstElI, and transcribed with T7 RNA Polymerase to synthesize a 279-nucleodde (nt) probe that produced a 224-nt protected band. To synthesize the a3(IV) collagen riboprobe, the 5' EcoRI fragment (nt 1-552) in BS H SK+ was cut with StyI (nt 187) and transcribed with T7 RNA Polymerase to make a 424-nt probe which produced a 365-nt protected band. The tx4(IV) collagen probe, also in BS II SK+, was cut with StyI (nt 694) and transcribed with T7 to make a 311-nt probe that was protected to the EcoRI site (nt 946) to produce a 252 nt band. For the collagen ~x5(IV) probe, the original RT-PCR product, cloned into the pCR II vector, was used. That plasmid was cut with AccI (nt 12 of the sense PCR primer) and transcribed with SP6 RNA Polymerase to produce a 461-nt probe and an ,'v381-nt protected band.
RNA Isolation and Analysis
RNA was prepared from mouse tissues by acid guanidinium phenol/chloroform extraction (Chomczynski and Sacchi, 1987) . Tissues were disrupted in the guanidinium solution with a Polytron. For RNase protection assays, 7/~g total RNA were hybridized with 1-5 x 109 probe molecules. Single-stranded RNA was digested with 1 U/ml RNase I"1 (United States Biochemical Corp.) and 0.4 ng/ml RNaseA (Sigma Chemical Co., St. Louis, MO). For details, see Miner and Wold (1991) .
Production of Fusion Proteins and Antisera
To produce collagen c~3-ct5(IV) proteins, fragments of their cDNAs coding for noncollaganous domain 1 (NC1) segments were cloned in frame into the proper pET-3 vector (Rosenberg et al., 1987) , all of which contain a common short leader sequence. The a3(IV) collagen fusion protein contained the final 184 amino acids of c~3(IV) collagen, the t~4(IV) collagen fusion protein contained its final 185 amino acids, and the et5(1V) fusion protein contained amino acids 120-248 (see Fig. 1 ). The pET-3 expression constrncts were transformed into the BL21(DE3) host strain (Novagen, Inc., Madison, WI) and then grown and induced for protein expression according to the manufacturer's instructions. Induced bacteria from a 50 rnl culture were pelleted, solubilized in sodium dodecyl sulfate loading buffer containing dithiothreitol, boiled for 5 rain, and electrophoresed through a preparative 10% SDS-polyacrylamide gel (Sambrook et al., 1989) . Proteins were visualized in the gel with 0.05 % Coomassie brilliant blue in water (Harlow and Lane, 1988) and excised with a razor blade. Gel slices were shipped to Cocalico Biologicals, Inc. (Reamstown, PA), where they were used to immunize rabbits. A second collagen ct4(iv) fusion protein, containing its final 151 amino acids, was used on Western blots (see Fig. 4 ) but not for immunization.
Antibodies and Immunohistochemistry
After initial characterization, one antiserum each to collagen c~3, ct4, and ct5(IV) was used for subsequent studies. The ct3 and ot4(IV) antisera initially recognized all three fusion proteins on Western blots, but subsequent experiments suggested that this was mainly due to reaction with the common ll-amino acid leader sequence. Thus, much of the cross-reactivity could be abolished by incubating diluted antisera with inclusion bodies containing the pET-3 leader sequence fused to a portion of S-laminin (pET-36; Hunter et al., 1989a) , which is unrelated to collagen IV. Most of the remaining cross-reactivity was removed by adsorption with inclusion bodies containing the noncognate collagen IV fusion proteins, followed by cantrifugation.
Goat antiserum to human collagen cd, c~2(IV) was purchased from Southern Biotechnology Associates, Inc. (Birmingham, AL). This antiserum reacted with mouse, rat, and human proteins. The collagen cd, ct2(IV) monoclonal M3F7 (Foellmer et al., 1983) , which reacts with rat and human proteins, was purchased from ICN Immunochemicals (Lisle, IL). Polyclonal (GPS) and monoclonal (C4) antibodies to S-laminin and monoclonal antibodies to laminin 131 ((221) and 132 (D18) have been described previously . Rabbit anti-human c~5(IV) collagen peptide antiserum was a kind gift of M. Kleppel (University of Minnesota Medical School, Minneapolis, MN).
Mouse and rat tissues were frozen in isopentane and sectioned at 4-8 pm on a cryostat. Human muscle biopsy material was provided by Kenneth Kaiser and Michael Brooke, then of the Department of Neurology, Washington University Medical Center (St. Louis, MO). In experiments involving the rabbit collagen IV antibodies, frozen sections were fixed in 100% ethanol for 5 rain at -20°C, rinsed in PBS, and treated with 6 M urea-O.1 M glycine, pH 3.5, for 1 h at 4°C, before antibodies were applied. The acid-urea treatment effectively exposed hidden collagen IV epitopes (Yoshioka et al., 1985) , but it also greatly increased background in rodent (but not human) tissues. This background was reduced but not eliminated by applying antibodies in PBS containing 5-10% nonfat dry milk. Fluorescein-and rhodamine-conjugated secondary antibodies to rabbit, goat, mouse, and guinea pig were obtained from Boehringer Mannfieim Biochemicals, Sigma Chemical Co., or Cappel/Organon Teknika (Durham, NC), and were also diluted in milk and applied for 1-2 h. In cases where muscle sections were not treated with urea-glycine, rhodamine-c~-bungarotoxin was added with the second antibody to label neuromuscular junctions.
Results
Cloning and Analysis of Mouse Collagen IV cDNAs
We used the published bovine ot3(IV) (Morrison et al., 1991) , bovine c~4(IV) (Mariyama et al., 1992a) , and human ot5(IV) ) collagen chain eDNA sequences to clone the corresponding mouse cDNAs (see Materials and Methods). A single 2.2-kb or3 clone, four a4 clones spanning 2.4 kb, and two or5 clones spanning 2.4 kb were isolated. Partial eDNA and deduced amino acid sequences of mouse collagen t~3-u5(IV) are shown in Fig. 1 . Mouse, human, and bovine NC1 amino acid sequences are compared in Fig. 2 (a-c), and Table I indicates that each human protein has a clear mouse ortholog. Fig. 2 d aligns the five cloned mouse collagen IV noncollagenous domain amino acid sequences, to show that all five sequences are highly related. Analysis of these sequences (Table II) indicates that the al, o~3, and or5 chains comprise one subgroup, while o~2 and o~4 comprise a second subgroup.
Collagen IV RNA Expression
To survey the tissue distribution of the collagen IV chains, we performed RNase protection assays of collagens al and t~3-a50V) expression using a panel of mouse tissue RNAs. The antisense RNA probes were synthesized so that the u3-o~50V)-protected fragments had identical specific activities and thus could be compared directly. The od(IV)-protected fragment was prepared at one-fourth of this specific activity, because we expected od0V) RNA to be more abundant than a3-ot5(IV).
In both neonates (Fig. 3 a) and adults ( Fig. 3 b) , high levels of collagen or(IV) RNA were detected in all tissues rich in BLs (heart, kidney, lung, muscle, and skin) whereas tissues with fewer BLs (brain and liver) expressed much less collagen cd(IV) RNA. In contrast, collagen c~3 and a4(IV) RNA were relatively abundant in only two of the tissues we tested, kidney and lung, while extremely low levels were detected O~KA~N~U~CL~CSCLPVrSr~C~I.OVCHV~Q~ 160 Figure 1 . Nucleotide and deduced amino acid sequences of collagen c~3(IV) (a), tx4(IV) (b), and c~50V) (c) cDNAs. Arrows denote the start of the COOH-terminal noncollagenous domains, and asterisks indicate points of fusion to an expression vector leader peptide for production of antisera. These sequences are available from EMBL/ GenBank/DDBJ under accession numbers Z35166, Z35167, and Z35168. in heart, muscle, and skin. The expression pattern of e5(IV) collagen is more similar to that of el(IV) than to that of e 3 and e4(IV), most notably in neonates. Absolute levels of e5(IV) RNA are, however, low, i.e., more similar to a3 and e4(IV) than to el(IV). Except for adult heart, where e3(IV) is absent but e4(IV) is just above the level of detection, there is great similarity between e3(IV) and a4(IV) collagen RNA ~5 100
Values of I>70% are in bold.
expression, consistent with the notion that they could be coregulated.
Collagen IV Protein Expression
Characterization of A,tisera. Based on these RNA analyses, we wanted to determine the cellular distribution of the collagen IV chains in a subset of BL-rich tissues. However, the collagen IV antibodies that had been useful for studies in human tissues did not work well for us on rodent tissues. We therefore used a bacterial expression system to produce recombinant proteins containing portions of the mouse collagen e3-e5(IV) NC1 domains fused to an 11-amino acid leader. The fusion proteins were purified by gel electrophoresis and used as immunogens to produce antisera in rabbits. Western blot analyses showed that none of the antisera recognized purified mouse el or a2(IV) collagen (data not shown). The e3 and o~4(IV) antisera showed cross-reactivity with all three fusion proteins, but >95 % of this cross-reactivity was removed by adsorption to the proper mixture of insoluble fusion proteins (Fig. 4 a) . As an initial test for the ability of these antibodies to recognize collagen IV in tissue sections, we used them, along with previously characterized antibodies to collagen el, 2(IV), to stain human kidney, in which the distribution of these chains has been previously documented (see Introduction). Staining required pretreatment of sections with urea/glycine, which is common for antibodies directed against components of BLs (Yoshioka et al., 1985) . Consistent with previous findings, anti-collagen el, 2(IV) recognized the glomerular mesangium and all TBMs but not GBM, while anti-e3, e4, and e5(IV) all recognized the GBM and a subset of TBMs (Fig. 
4, b-e).
Based on these immunoblotting and immunofluorescence results, we conclude that our new antibodies exhibit appropriate reactivities.
Kidney. In adult mouse (Fig. 5, a-d) and rat (Fig. 5, e-h) kidneys, anti-collagen el, e2(IV) antibodies stained all TBMs, the BLs of blood vessels, and the glomerular mesangial matrix intensely, but stained the GBM poorly. The anti-collagen e3, e4, and e5(IV) rabbit antisera stained the Figure 3 . Ribonuclease protection analyses of collagen IV chain gene expression in tissues of newborn (a) and adult (b) mice. 7 #g of total RNA were used to protect each probe, and yeast type HI RNA was used as a negative control. The c~3-c~5(IV) protected fragments had the same specific activity, so their signal intensities are proportional to their relative abundance; the cd(IV) probe had onefourth of this specific activity. Note that the lower band of the doublets observed for ~x4 in b is background, as it also appears in the yeast lane.
GBMs intensely and also stained a great majority of the cortical and inner medullary TBMs, but the mesangium, blood vessel BLs, and a large subset of TBMs in the outer medulla were not stained. We could detect no significant differences in localization among the o~3-cx5(IV) collagen chains. The overall pattern of collagen IV chain expression was very similar in adult mouse and rat kidneys, as well as in rodent and human glomeruli. However, we consistently observed a significant difference between human and rodent tubules. In human, TBMs of a small subset of tubules identifiable as distal tubules (Kleppel et al., 1989) are stained with the collagen ot3-ot5(IV) antisera (Fig. 4, c-e) . In the rodent cortex, in contrast, both proximal and distal TBMs were stained (Fig. 5 f a n d data not shown; note that Western analysis of rabbit anti-collagen c~3-c~5(IV) antisera reactivity with collagen IV fusion proteins. Each lane contained all three bacterially produced fusion proteins, as indicated. Before being applied to blots, the ot3(IV) antiserum was adsorbed with inclusion bodies containing S-laminin and collagen ~x4 and c~5(IV) fusion proteins; the a4(IV) antiserum was adsorbed with inclusion bodies containing S-laminin fusion protein; and the c~5(IV) antiserum was adsorbed with inclusion bodies containing collagen or3 and ~x4(IV) fusion proteins. The S-laminin fusion protein ~pET-36) contains the same pET leader peptide as the collagen IV fusion proteins. (b-e) Immunohistochemical analysis of collagen IV chains in human kidney, b shows staining with mouse mAb M3FT, which is specific for collagen ~xl, 2(IV); staining is most prominent in tubular basement membranes (TBMs) and in glomerular mesangium, c-e show staining with adsorbed rabbit anti-collagen a3-~x50V), respectively. Staining is intense in GBM and a subset of TBMs but is absent from other TBMs and the mesangium. G, glomerulus; T, tubule. Bar, 50 #m. Skin. To determine if collagens a3-a5(IV) are codistributed generally, we used these antibodies to stain sections from skin, in which RNase protection had shown higher levels of a5(IV) than of a 3 and c~40V) RNAs (Fig. 3) . In both rat (Fig. 6 ) and mouse (data not shown) the epidermal basement membrane was brightly positive for al, a2, and aS(IV) collagen chains (Fig. 6, a, c, and d) , but collagen a3 and a4(IV) were nearly undetectable ( Fig. 6 b and data not  shown) . Thus, the collagen a3, a4 and c~5(IV) chains are not always colocalized.
Muscle. The BL at the neuromuscular junction is morphologically and functionally distinct from the extrasynaptic BL. Much of our interest in the collagen IV chains stems from our finding in human muscle that a3 and a4(IV) chains are restricted to the neuromuscular junction, whereas cd 'and a2(IV) are less abundant synaptically than extrasynaptically . The data presented in Fig. 7 , a and b, extend these results by showing that collagen a5(IV) is also concentrated in human muscle synaptic BL, as determined by using both our rabbit antiserum (Fig. 7 a) and a humanspecific peptide antiserum (Fig, 7 b ). Synapses were identified by their staining with rhodamine-labeled a-bUngarotoxin or an antibody to S-laminin, a laminin BI homologue expressed at neuromuscular junctions (Hunter et al., 1989b) . In the rat (Fig. 7, c-f ) and mouse (data not shown), collagen cd and a2(IV) were expressed in all BLs except for . All sections were doubly labeled to identify synaptic sites, using either mouse anti-S-laminln (a', and d'-f') or rhodamine-c~-bungarotoxin (b' and c'). Arrow in c notes the ~-bungarotoxin-positive synaptic BL that is collagen al, 20V) negative. In rat, collagen c~5(IV) appears more abundant at synapses than a3(IV) and a4(IV) collagen chains, but it also is found extrasynaptically at lower levels in some muscle fibers (f). Bar, 20 ~m. synaptic BL, while ct3 and a4(IV) were detectable only in the synaptic BL. ot5(IV) collagen was also concentrated at synapses, but low levels of this chain were also detectable extrasynaptically in many muscle fibers in both rat and mouse.
Collagen I V and Laminin Subunit Associations
Results presented previously and above show that glomerular and muscle synaptic BLs in human, mouse, and rat express the S-laminin and o~3-o~5(IV) collagen chains. We performed a series of double-labeling studies to determine if there is a general association of S-laminin with collagen o~3-c~5(IV), and/or of laminin B1 with collagen od and ot2(IV). Results for rat kidney are shown in Fig. 8 , and data from all tissues examined are summarized in Table HI . In kidney, S-laminin was associated with collagen ot3-o~5(IV) chains in GBM but with collagen cd, 2(IV) chains in blood vessels. Similarly, the collagen ~3-c~5(IV) chains could associate either with S-laminin (in GBM) or with laminin BI (in TBM). Other combinations were observed elsewhere (Table III) . Thus, there is no exclusive association of collagen od, 2(IV) with laminin B1, or of collagen c~3-ol5(IV) with S-laminin.
Collagen I V and Laminin Subunit Expression during Development
Collagen ,3-ot50V) chains have so far been studied mostly in adults because, as noted in the Introduction, most studies have been restricted to human material. The availability of probes for rodent mRNA and protein facilitates study of these chains during development. Here, we focus on kidney, because it is rich in all of the collagen IV chains, as well as both S and B1 subunits of laminin. Moreover, kidney development proceeds postnatally in a graded fashion such that a single kidney section from the first postnatal week contains glomeruli and tubules at all stages of development, with the most primitive structures found in the outermost part of the cortex (Ekblom, 1981; Davies, 1993) .
Glomeruli. As the first step in nephron development, the ureteric bud branches into nephrogenic mesenchyme and induces it to condense into a sphere and epithelialize. This vesicle then undergoes a defined progression of morphogenetic changes that result in its transformation into a glomerulus. Successive stages are termed comma-shaped, S-shaped, capillary loop, immature glomerular, and mature glomerular (Sorokin and Ekblom, 1992; Davies, 1993) . As noted above, nephrons are added at the cortical surface, and all stages of development are encountered successively in a cortico medullary traverse. In the newborn rat, GBMs at all but the most mature stages contained collagen txl, 2(IV) (Fig. 9, aand c) . Glomeruli from the capillary loop stage and onward also harbored collagen c~3-c¢5(IV) in their BLs, here represented by a3fiv) staining (Fig. 9, b and d) . In the most mature glomeruli, collagen od and ot2(IV) were no longer abundantin the GBM but were present at a high level in the mesangial matrix (Fig. 9 c) . Thus, there is a progression of collagen IV. ieffiain expression in the GBM: only oil and c~2(iv) are detected initially; then txl-tx5(IV) are all present; and finally, a3-o~5(iv) become the predominant chains. This' transition raised the question of whether collagenlaminin associations changed during development. To examine this issue, we stained sections from the same blocks with antibodies to the laminin S, B1, and B2 subunits. Interestingly, the transition in collagens IV is accompanied by an isoform transition in laminin Bl-like subunits. Laminin B1, like collagen od, 2(IV), was found in all developing GBMs (Fig. 9 e) , while S-laminin, like the collagen o~3-ot5(IV) chains, was first detected at the capillary loop stage (Fig. 9  f) . In fact, we could find no developing glomeruli that contained S-laminin but not the collagen o~3-a5(IV) chains, and the converse was also true. In the most mature glomeruli, laminin B1 was no longer found in GBM but was abundant in the mesangium (Fig. 9 g ), while S-taminin remained in the GBM (Fig. 9 h) . Consistent with its being the most widely expressed subunit of the laminin trimer, laminin B2 was found in both the GBM and the mesangial matrix at all stages of glomerular development (Fig. 9, i and j) .
Tubules. The tubular portion of the nephron forms as an extension of one end of the S, shaped structure, which fuses to the ureteric bud/collecting duct, elongates, and convolutes. In neonates, tubules expressed collagen al, 2(IV) and laminin B1 and B2 but not collagen ot3-a5(IV) or S-laminin (Fig. 9) . By P7, restricted groups of TBMs had begun to accumulate the a3-tx5(IV) collagen chains ( Fig. 9 k and data not shown). All tubules continued to express collagen c~l, 2(IV) and laminins B1 (and B2; data not shown), while S-laminin was never detected in TBM (Figs. 5 and 8) . Thus, both tubular and glomerular BLs acquire collagens ct3-c~5(iv) late in development, but only in glomeruli is this switch accompanied by the loss of cd,2(IV) and laminin B1 and the acquisition of S-laminin.
Discussion
To learn how structural differences among BLs contribute to their functional specialization, it is important to ascertain the makeup of individual BLs in an experimentally accessible mammal, in which genetic and surgical manipulations are possible. To this end, we have cloned and characterized cDNAs encoding the ct3OV), ot4(IV), and c~5(IV) chains of mouse collagen IV. We produced antisera to the respective recombinant proteins and then used them along with previously characterized antibodies to determine the combinations of collagen IV chains and laminin subunits found in the BLs of several tissues. We thereby extended previous work on the molecular heterogeneity of BLs in adult animals, and provided new evidence for systematic changes in composition of individual BLs during development.
The Collagen IV Gene Family
Analysis of the txl-c~5(IV) NCI domain sequences shows that the five mouse proteins have unequivocal human orthologs and can be divided into two evolutionarily related groups: al, ct3, and ct5(IV); and or2 and cz4(iv). Such a relationship has previously been noted for the bovine and human collagen IV chains (Mariyama et al., 1992a) and is consistent with the paired, head-to-head arrangement of od with c~2(IV) (Poschl et al., 1988) , ct5 with ct6(iv) , and probably ct3 with ct4(IV) (Morrison et al., 1991; Turner et al., 1992; Mariyama et al., 1992b; Kamagata et al., 1992) . This arrangement suggests that a single, ancestral collagen IV gene was duplicated and inverted to form a headto-head pair, which was then duplicated twice to yield the three present day loci (Hudson et al., 1993) . NC1 domain comparisons also show that the od(IV) chain is more similar to a5(iv) than to o¢3(IV) ( Table I) , and comparisons with invertebrate collagen IV genes indicate that cd(IV) collagen is most similar to the presumed ancestral collagen IV chain (Quinones et al., 1992) . Taken together, these observations suggest the following scheme: an ancestral collagen IV gene, today represented by the widely expressed cd(IV), duplicated and inverted to produce the otl/tx2(IV) locus. This locus then duplicated twice, first to produce the cz3/a4(IV) pair and then again to produce the cz5/ot6(IV) locus.
It has been determined that the paired cd and ot2(IV) genes share a common, bidirectional promoter (Soininen et al., 1988; Poschl et al., 1988; Burbelo et al., 1988) . Given the likelihood that the two other collagen IV pairs arose by duplication of that locus, the ot3/u4(IV) and o~5/ct6(iv) gene pairs may be similarly regulated. Indeed, the transcription start sites of the collagen ct5 and o~6(IV) genes are separated by under 500 bp in both human (Zhou et al., 1993) and mouse (J. H. Miner, unpublished) , and our RNA expression data (Fig. 3) support the notion of coordinate regulation of ct 3 and 0¢4(IV). The expression pattern of the oe5(IV) collagen gene is similar to that of od(iv), albeit at lower levels, and this correlates with the closer evolutionary relationship between these genes, presumably including their regulatory regions.
Coordinate and Independent Regulation of Collagen IV Chains
To study the localization of collagen IV chains in rodent BLs, we needed to produce antisera to mouse collagen t~3, or4, and a5(IV) fusion proteins, because the antibodies that had worked well on human sections failed to stain mouse or fat sections. However, due to the extensive similarity among the members of the collagen IV gene family (Fig. 2 d) , we realized that each antiserum might react with all of the collagen IV chains. To test for cross-reactivity, we performed Western blot analyses, which showed that the three antisera did not recognize purified collagen ul or ot2(IV). The or3 and t~4(IV) antisera initially reacted with all three fusion proteins, but adsorption to the proper mixture of insoluble fusion proteins removed nearly all of this crossreactivity (Fig. 4 a) .
The behavior of our antisera in immunohistochemical assays provides additional evidence that they do not cross-react with collagen ul or ct2(IV). For example, we found many sites of abundant collagen t~l, 2(IV) expression which were negative for ct3-ot5(IV) (Table m); this would not be observed if our antisera cross-reacted with the od or o~2(IV) chains. Also, the absorbed ct3(IV) and ct4(IV) antisera did not stain a5(IV)-positive extrasynaptic muscle or skin (Table  IH) BLs, indicating that neither recognized o~5(iv).
We found that the collagen t~l and ct2(IV) chains are widely distributed in many BLs, whereas the ot3-o~5(lV) chains are more restricted in their expression (Table III) . In the adult, collagen or3 and ot4(IV) chains were consistently coexpressed, as shown by immunohistochemical and RNase protection assays. This is consistent with the hypothesis that they are coregulated and with the finding that their NC1 domains associate with each other (Johansson et al., 1992) . However, while the collagen c~5(IV) chain accompanied or3 and a4(IV) in GBM, TBM, and synaptic BL, the epidermal BL was strongly positive for collagen o~5(IV) but contained little collagen a3 or o~4(IV). Taken together, our results document four patterns of collagen IV expression in adult rodent BLs: al-~5(IV) (e.g., in some TBMs); ul, or2, and ct5(IV) (e.g., in epidermal BL); od and c~2(IV) (e.g., in blood vessel and nerve BLs); and ct3-ct5(IV) (e.g., in GBM and synaptic BL). So far we have not found BLs which contain collagen c~3 and t~4(1V) but not ct5(IV), and we have never found o~5(IV) alone. These results are consistent with those obtained using human tissues (Kleppel et al., 1989a; Sanes et al., 1990; Hostikka et al., 1990) . However, one important difference in collagen IV expression between rodents and humans is that the majority of TBMs present in a typical rodent kidney section are positive for ot3-a5(IV) collagen chains (Fig. 5) , whereas in human kidney such TBMs are rare (Fig. 4, b-d) and have been identified as distal TBMs (Kleppel et al., 1989a, b) . Another notable difference between rat and human is revealed by the collagen oe5(IV) staining pattern in muscle: while ot5(iv) collagen is concentrated at synapses in both rat and human muscle, it is also found extrasynaptically in some rat muscle fiber BLs, though at much lower levels ( Fig. 7 and data not shown) .
Relationship of Collagen IV and Laminin B Chains
Like the collagen cd and ct2(IV) chains, the laminin B1 subunit (/31) is widely expressed; like the oe3-a5(IV) chains, S-laminin (/~2) is restricted to a small subset of BLs. In some cases, the expression patterns of these BL components exhibit remarkable parallels. For example, S-laminin and collagen ot3-oe5(IV) are concentrated at the neuromuscular junction and in GBM, and laminin B1 and collagen od and ot2(IV) are absent or greatly diminished at both sites. Likewise, extrasynaptic muscle BL is rich in laminin B1 and collagen cd and a2(IV), whereas S-laminin and ot3-ct5(IV) are absent or greatly reduced compared with synaptic BL. However, these parallel patterns are not obligatory. Collagens c~3-oe5(IV) are found without S-laminin in TBMs, and S-laminin is found without a3-t~5(IV) in blood vessels. Likewise, collagen otl and ~t2(IV) are found without laminin B1 in blood vessels. We have, however, found no BLs in which laminin B1 is unaccompanied by the od and a20V) collagen chains.
Replacement of Basal Lamina Components during Renal Development
In the earliest stages of glomerular development (vesicle, comma, and S-shaped structures) we found BLs that contained collagen cd and ot2(IV) and laminin B1. At the capillary loop stage, we began to detect collagen ot3-o~5(IV) and S-laminin in the GBM; these appeared coordinately and were colocalized with collagen oil and o~2(IV) and laminin B1. This coordinate appearance is noteworthy, because even though there is no obligatory association between collagen c~3-t~5(IV) and S-laminin, they appear to be coregulated in this instance. Finally, as glomeruli matured, we found that collagen od and ot2(IV) and laminin B1 became concentrated mainly in the mesangium, while the GBM continued to accumulate ct3-u5(IV) and S-laminin. Thus, during GBM development, collagens ct3-ct5(IV) replace od and ~2(IV), and S-laminin replaces laminin B1. A laminin B1 to S-laminin switch has also been reported in developing nerve (Jaakkola et al., 1993) , and previous studies on fetal human kidney provided preliminary evidence for the collagen IV switch that we have documented here (Kleppel and Michael, 1990) . At least in kidney, this appears to be a true replacement rather than the formation of a totally new BL because double-labeling experiments revealed a colocalization of the late-appearing isoforms with their more widely distributed counterparts (Fig. 9) . However, interspecies grafting experiments and ultrastructural analyses have shown that the mature GBM forms from fusion of separate endothelial and epithelial BLs (Sariola et al., 1984; Abrahamson, 1985) . Thus, it is possible that one of these BLs contains collagen ct3-t~5(IV) and S-laminin and the other cd, t~2(IV), and laminin B1. In any event, since collagen t~l, t~2(IV), and laminin B1 are eliminated from the maturing GBM (Desjardins and Bendayan, 1991; Abrahamson and St. John, 1992 ; Fig. 9 ) as t~3-a5(IV) and S-laminin appear, there must be some mechanism to coordinate the transition.
BL composition also changes in developing TBMs, but in a different way. All TBMs at all stages were positive for collagen od and ~t2(IV) and laminin B1, but we never detected S-laminin, and significant amounts of ~ 3-et5(IV) did not acthe or4 and ot5(IV) collagen antisera (data not shown), e and g are stained for laminin B1 and show a pattern virtually identical to collagen or, 2(IV). These same sections viewed for S-laminin (f and h) show glomerular staining very similar to collagen t~3(IV), i and j show laminin B2 staining at all stages of nephron development, but in contrast to laminin B1, B2 remains in mature GBM. (k) By P7, many TBMs are positive for t~4(IV) (compare P0, b and d). U, ureteric bud; S, comma and S-shaped structures; C, capillary loop BL; G, glomerulus. Bar, 50 gm. cumulate until P7. Thus, there is a relatively late addition of collagen a3-a5(IV) to od and ct2(IV) in TBM that is not synchronous with their appearance in GBM.
The replacement of collagen cd, 2(IV) and laminin B1 with collagen c¢3-c¢5(IV) and S-laminin in the developing GBM is reminiscent of the embryonic to adult myosin and the fetal to adult hemoglobin switches (Whalen et al., 1981; Maniatis et al., 1980) . However, the collagen IV and laminin switches are different in that what are "fetal" isoforms in some tissues persist into adulthood in others. This suggests that there are distinct mechanisms for spatial and temporal regulation of the individual BL components in different tissues. It is noteworthy to mention here that in Alport syndrome, in which one or more of the ot3-ct6(IV) collagen chains are absent, there is a marked increase in oil and ot2(IV) chains in the GBM (Kashtan and Kim, 1992) . This can be viewed as a reactivation of the "fetal" isoforms, which may act to slow the onset of end-stage renal disease in Alport patients. Moreover, it implies that there is a mechanism for reactivating fetal BL components and assembling them into mature (though compromised) BLs.
